Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 11,926

Document Document Title
WO/2018/098553A1
A method of making an antibody in plants that binds to ricin is described. The method comprises (a) introducing a nucleic acid molecule encoding a heavy chain variable region of the antibody and a nucleic acid molecule encoding a light c...  
WO/2018/099493A1
Tropaeolum majus granules and a preparation method therefor. Said granules comprise in parts by weight: 10 to 20 parts of Tropaeolum majus, 3 to 8 parts of Glebionis coronaria, 3 to 5 parts of superfine powder of the stem and leaf of swe...  
WO/2018/100178A1
The invention provides a method for the production of a zeolite particle composition which has optimized characteristics, such as enhanced adsorption and specific ion exchange properties. A method and an apparatus for producing improved ...  
WO/2018/089752A1
The present invention provides a method of treating subjects with non-ischemic dilated cardiomyopathy by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells. The present i...  
WO/2018/081858A1
The present invention relates to new desferrioxamine B analogues that are useful for iron-chelation therapy, to their preparation including intermediates, and to compositions including the compounds. The present invention also relates to...  
WO/2018/081903A1
There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of cardiovascular diseases, and method for the treatment th...  
WO/2018/079832A1
The present invention addresses the problem of providing an agent for reducing uremic substances in the blood which has an action of effectively lowering (reducing) the concentration of uremic substances in the blood, and a prophylactic ...  
WO/2018/079702A1
The present invention provides a lactoferrin fusion protein having high clinical utility and a production method therefor. The present invention further provides: a lactoferrin fusion protein that retains the biological activity of nativ...  
WO/2018/077312A1
Disclosed is an effervescent tablet for enhancing immunity, said effervescent tablet comprising the following components in parts by weight: 50-200 parts of vitamin C sodium, 10-30 parts of taurine, 10-30 parts of zinc gluconate, and 10-...  
WO/2018/079178A1
A refined chlorogenic acid-containing composition manufacturing method including a contact step in which a chlorogenic acid-containing composition with a solid content concentration of 1.5-4.7 mass% and a mass ratio of caffeine/chlorogen...  
WO/2018/075641A1
The present invention relates to methods for attenuating aging, of health maintenance, and/or treating, or delaying the onset of, an age-related condition or disorder, in a subject comprising administering to the subject an effective amo...  
WO/2018/071323A1
A method for assessing susceptibility to nausea of a patient comprises assessing the GSH recycling dependent antioxidant activity of the patient's blood cells prior to receiving an emetogenic agent, e.g., a cytostatic agent or a surgical...  
WO/2018/063010A9
The invention relates to a novel lupeol derivative, which is the ester of 4-picolinic acid (isonicotinic acid) and 20(29)-lupen-3.beta.-ol (lupeol), having structural Formula (1). The novel lupeol derivative is a result of modification o...  
WO/2018/063010A1
The invention relates to a novel lupeol derivative, which is the ester of 4-picolinic acid (isonicotinic acid) and 20(29)-lupen-3.beta.-ol (lupeol), having structural Formula (1). The novel lupeol derivative is a result of modification o...  
WO/2018/059922A1
The present invention relates to a film-coated swallowable tablet comprising deferasirox in an amount of at least 60% by weight based on the total weight of the tablet and poloxamer, wherein the weight ratio of deferasirox to poloxamer i...  
WO/2018/053397A1
The invention relates to methods of treating or preventing organophosphate poisoning in a subject in need thereof, comprising administering to the subject isoflurane, enflurane, halothane, sevoflurane, desflurane, xenon or argon in a the...  
WO/2018/050938A1
The invention relates to a pre-loaded injectable device comprising or consisting of the composition according to the invention, the injectable pharmaceutical form, the combined preparation, or the pre-loaded injectable device for treatin...  
WO/2018/048812A1
Provided herein are pharmaceutical formularions comprising a 1,2-HOPO chelating agent and/or 3,2-HOPO chelating agent.  
WO/2018/035613A1
Disclosed are chelating co-polymer compositions that are soluble in aqueous media and chelate essential metals, methods of preparation and uses thereof. The chelating compositions are comprised of two or more different monomers, at least...  
WO/2018/039487A1
The invention provides compounds having the general formula I: and pharmaceutically acceptable salts thereof, wherein the variables R1, R2, R3, R4, subscipt m and n, have the meaning as described herein, and compositions containing such ...  
WO/2018/039526A1
Methods for managing pain, treating pain, and treating neurodegenerative disorders. The methods include administering to a subject in need thereof: (A) a therapeutically effective amount of simvastatin or a pharmaceutically acceptable sa...  
WO/2018/033249A1
The present invention provides a pharmaceutical preparation and in particular a combination of a pharmaceutical preparation and hyaluronic acid for use as a medicament, wherein the pharmaceutical preparation is injected into an intact sk...  
WO/2018/033226A1
The present invention provides a pharmaceutical preparation for use by injection into the skin, wherein the pharmaceutical preparation is preparable by a production method comprising the steps of providing a liquid collected from an orga...  
WO/2018/033227A1
The present invention relates a pharmaceutical preparation for use in the treatment of ageing or as an anti-ageing agent, which is preparable by a production method comprising the following steps: providing a liquid collected from an org...  
WO/2018/023857A1
Provided are a Ganoderma polysaccharide, combination thereof, and manufacturing method of same. The Ganoderma polysaccharide is a Ganoderma lingzhi polysaccharide with a potassium ligand. The polysaccharide provides the following benefit...  
WO/2018/024887A1
The invention relates to a composition for use in the therapy of veisalgia. The composition comprises at least one sugar compound, mineral salts, at least one compound for cell protection, at least one compound for promoting cell functio...  
WO/2018/018783A1
A method for manufacturing a probiotics finishing agent, comprising the following steps: culturing probiotics; microencapsulating the probiotics; enabling the probiotics to be dormant; and blending an adhesive of microcapsules. The metho...  
WO/2018/021447A1
The purpose of the present invention is to provide a novel compound having D3 receptor antagonistic effect. Provided are the following: a compound represented by formula (I) (in the formula, ring A is a heterocyclic ring, X1 groups are e...  
WO/2018/016393A1
The present invention addresses the problem of providing a composition for preserving deoxyribonucleic acid which secures a sufficient supply amount and contributes to production cost reduction. The composition according to the present i...  
WO/2018/016523A1
Provided is a novel radioprotectant that comprises a compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient [in formula (I): a ring A represents a fused ring; and R1 represents a hydroge...  
WO/2018/015602A1
The present invention discloses the amino-terminal sequence of avian albumin bound to divalent cations such as copper or zinc, and any recombinant or fusion protein comprising said sequence for use thereof as a medicinal product, specifi...  
WO/2018/014068A1
The present invention provides a combination therapy for treating a tumor in a subject. The combination therapy comprises administration of (i) an antibody which binds to a cell surface-associated antigen expressed on the tumor cell, and...  
WO/2018/014068A9
The present invention provides a combination therapy for treating a tumor in a subject. The combination therapy comprises administration of (i) an antibody which binds to a cell surface-associated antigen expressed on the tumor cell, and...  
WO/2018/014067A1
The present invention provides a combination therapy for treating a tumor in a subject. The combination comprises two elements. The first is a polypeptide construct comprising an attenuated Type 1 interferon (IFN) linked to an antibody w...  
WO/2018/010588A1
A therapeutic agent for restoring body function aging and delaying organ function decline, and particularly a therapeutic agent comprising mesenchymal stem cells, especially stromal cells having positive expression of GD2 and hematopoiet...  
WO/2018/014016A1
Substance P analogs are useful for treating and protecting against exposure to ionizing radiation such as acute radiation syndrome, chronic radiation syndrome and the like. The active agents can be administered via inhalation therapy, in...  
WO/2018/010332A1
The present invention belongs to the field of pharmaceutical chemical technologies, and in particular relates to the use of 7-hydroxy-butyphthalide in the preparation of drugs for preventing and/or treating cardiovascular and cerebrovasc...  
WO/2018/000047A1
The present invention relates to the use of substituted quinoline compounds for treating immunoglobulin light chain (LC) amyloidosis (AL), especially cardiotoxicity associated with immunoglobulin LC AL. In particular, the substituted qui...  
WO/2018/001273A1
Provided are a peptide or a salt thereof, and a preparation method therefor. The peptide may be selected from VVYP, AVLP, IGFP, LLIIVP and STAP. The preparation method comprises steps as follows: using a resin as a starting material, lin...  
WO/2017/218845A1
Oxidative stress is linked to several health conditions including, without limitation, cancer, aging, neurodegenerative and metabolic diseases. Increased levels of oxidative stress may result from increased exposure to radiation or other...  
WO/2017/211617A1
The present invention relates to a compound for use as a medicament in the treatment or prevention of acute liver failure, which acute liver failure is induced by intoxication prior to or following administration of the compound. Accordi...  
WO/2017/206026A1
Disclosed are a composition and use thereof, the composition comprising the following components in parts by weight: 1 to 500 parts o f astaxanthin; 1 to 1000 parts of a potassium salt; 1 to 500 parts of a calcium salt; 1 to 500 parts of...  
WO/2017/208172A1
The present invention relates to a composition for use as a medicament, in the form of a gel with characteristics of a reversible thermogel, based on one or more poloxamers, water and optionally excipients, and an effective amount of an ...  
WO/2017/206105A1
An edible composition comprising an insoluble fiber and a prebiotic and liquid-absorbable gel can reduce the digestion or absorption of the harmful/toxic substance existed in food or drink.  
WO/2017/209934A1
An autophagy activator, such as vitamin D, for use in a method of treating or preventing skin damage in a subject in need thereof is described, that includes administering to the subject a therapeutically effective amount of said activat...  
WO/2017/204619A1
The present invention provides an aqueous extract of Andrographis paniculata leaves containing as main components andrographolide, neoandrographolide and 14-deoxy-11,12-didehydroandrographolide. The Invention also provides a method of pr...  
WO/2017/197793A1
A life-prolonging liquor, consisting of the components of: 10 g of Herba Cistanche, 20 g of Radix Rehmanniae, 10 g of Radix Rehmanniae Preparata, 10 g of Radix Asparagi, 10 g of Radix Ophiopogonis, 20 g of Radix Angelicae Sinensis, 10 g ...  
WO/2017/199073A1
An oral pharmaceutical formulation for effervescent tablet of deferiprone is reported comprising of deferiprone and a taste-masking composition consisting of an effective amount of sweetener and flavoring agent and containing appropriate...  
WO/2017/197781A1
The present invention provides a health-care and body-strengthening Fructus Lycii liquor, comprising the following components: Fructus Lycii: 50 g; Flos Chrysanthemi: 50 g; Radix Rehmanniae Preparata: 45 g; stir-baked Massa Medicata Ferm...  
WO/2017/195359A1
This hop processed product for suppressing fat accumulation or for antioxidation contains greater than or equal to 50 wt%, preferably greater than or equal to 60 wt%, and most preferably greater than or equal to 70%, of hop flowers (E・...  

Matches 1 - 50 out of 11,926